“dana-farber-cancer-institute” Archives

in
Entry Author Date Location
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding 12/04/19 Boston
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels 10/07/19 National
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
What’s Hot in Boston Biotech 2019: The Photos 06/04/19 Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Save $100 Today on “What’s Hot in Boston Biotech” on May 16 05/02/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Quentis Nets $48M For Cancer Drugs, Building Buzz For NY Bio Startups 02/27/18 New York
The Winners of the 2017 Xconomy Awards Are… 09/26/17 Boston
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Last Chance to Snag a Ticket for What’s Hot in Boston Biotech 05/10/17 Boston
Grab Your Ticket for What’s Hot in Boston Biotech on May 11th 05/03/17 Boston
Cellular Dynamics Adds to Stem Cell Work With Harvard Institute 04/25/17 Wisconsin
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Veering Off Topic With General Catalyst’s Larry Bohn 03/10/17 Boston
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy 12/02/16 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Amid Leadership Changes, NY Biotech Braces For its “Pivotal Moment” 05/12/16 New York
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall 03/07/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Page 1 of 4 next page »